Erythrocyte aging: a comparison of model systems for simulating cellular aging in vitro - PubMed (original) (raw)

Affiliations

PMID: 3179456

Comparative Study

Erythrocyte aging: a comparison of model systems for simulating cellular aging in vitro

G J Bosman et al. Blood Cells. 1988.

Abstract

Senescent cell antigen (SCANT) is a "neo antigen" that appears on the surface of normal old cells and initiates IgG binding and cellular removal. To investigate the mechanism by which SCANT is generated from its parent molecule, band 3, we subjected intact human erythrocytes to treatments that have been reported to result in changes in band 3 and/or to mimick aging in vitro. The validity of these treatments as model systems for erythrocyte aging was evaluated using a "red cell aging panel" that provides a biochemical profile of a senescent red cell. Treatments were assessed for their ability to induce in vitro the following changes observed in normal erythrocytes aged in vivo: 1 increased breakdown of band 3 as detected by immunoblotting, 2 decrease in anion transport efficiency as detected with a sulfate self-exchange assay, 3 decrease in total glyceraldehyde 3-phosphate dehydrogenase activity with an increase in membrane-bound activity, and 4 increase in the binding of autologous IgG as detected with a protein A binding assay. Neither incubation with the free radical-generating xanthine oxidase/xanthine system, nor treatment with malondialdehyde, and end product of free radical-initiated lipid (per)oxidation, results in age-specific changes. Loading of the cells with calcium and oxidation with iodate results in increased breakdown of band 3, but does not lead to increased binding of autologous IgG. Only erythrocytes that have been stored for 3-4 weeks show the same structural and functional changes as observed during aging in vivo.

PubMed Disclaimer

Cited by

Oxidative stress and caspase-mediated fragmentation of cytoplasmic domain of erythrocyte band 3 during blood storage.
Rinalducci S, Ferru E, Blasi B, Turrini F, Zolla L. Rinalducci S, et al. Blood Transfus. 2012 May;10 Suppl 2(Suppl 2):s55-62. doi: 10.2450/2012.009S. Blood Transfus. 2012. PMID: 22890269 Free PMC article.
Molecular mapping of human band 3 aging antigenic sites and active amino acids using synthetic peptides.
Kay MM. Kay MM. J Protein Chem. 1992 Dec;11(6):595-602. doi: 10.1007/BF01024959. J Protein Chem. 1992. PMID: 1281633
Alteration in membrane protein band 3 associated with accelerated erythrocyte aging.
Kay MM, Flowers N, Goodman J, Bosman G. Kay MM, et al. Proc Natl Acad Sci U S A. 1989 Aug;86(15):5834-8. doi: 10.1073/pnas.86.15.5834. Proc Natl Acad Sci U S A. 1989. PMID: 2527366 Free PMC article.
Changes in band 3 structure as determinants of erythrocyte integrity during storage and survival after transfusion.
Bosman GJ, Stappers M, Novotný VM. Bosman GJ, et al. Blood Transfus. 2010 Jun;8 Suppl 3(Suppl 3):s48-52. doi: 10.2450/2010.008S. Blood Transfus. 2010. PMID: 20606749 Free PMC article. Review. No abstract available.
Definition of a physiologic aging autoantigen by using synthetic peptides of membrane protein band 3: localization of the active antigenic sites.
Kay MM, Marchalonis JJ, Hughes J, Watanabe K, Schluter SF. Kay MM, et al. Proc Natl Acad Sci U S A. 1990 Aug;87(15):5734-8. doi: 10.1073/pnas.87.15.5734. Proc Natl Acad Sci U S A. 1990. PMID: 1696010 Free PMC article.

Erythrocyte aging: a comparison of model systems for simulating cellular aging in vitro - PubMed (original) (raw)